why choose us

Clinical Trials Search

Showing 7,060 of 132,085 result(s)
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms in Hispanic Individuals

Status: Completed

Condition: Caregiver Burden

Interventions: The Brain CareNotes mobile telehealth app is used by unpaid caregivers for BPSD management.
It includes remote communication with an external hum

Date: 2023-10-19

Culturally Tailored HPV Psychoeducational Multimedia Intervention

Status: NOT_YET_RECRUITING

Condition: Health Knowledge, Attitudes, Practice

Interventions: The culturally tailored multimedia psychoeducational intervention will involve audio and visual content and will be delivered in a bilingual fashion (

Date: 2023-10-19

Parent Led Implementation of a VR Social Skills Training Program for Children With ASD

Status: NOT_YET_RECRUITING

Condition: Autism Spectrum Disorder

Interventions: The intervention will consist of two episodes of the Floreo BSC program, each lasting 4-5 minutes, according to a fixed program of episodes determined

Date: 2023-10-19

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced;Metastatic Solid Tumors

Status: Completed

Condition: Advanced Solid Tumor

Interventions: Investigational drug monotherapy

Date: 2023-10-19

LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)

Status: Completed

Condition: Non-small Cell Lung Cancer

Interventions: Stereotactic ablative radiotherapy (SABR) or interventional radiology (IR) ablation therapy

Date: 2023-10-19

A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

Status: Completed

Condition: Non-Small Cell Lung Cancer

Interventions: Fixed dose coformulated product of hyaluronidase;pembrolizumab adminstered via SC injection.

Date: 2023-10-19

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

Status: NOT_YET_RECRUITING

Condition: Advanced Melanoma

Interventions: Soluble PRAME-specific T cell receptor with anti-CD3 scFV concentrate for solution for intravenous (IV) infusion at a unit dose of 0.2 mg;mL.

Date: 2023-10-19

Controlled Arterial Protection to Ultimately Remove Embolic Material

Status: NOT_YET_RECRUITING

Condition: Aortic Valve Stenosis

Interventions: The EmStop Embolic Protection System (EmStop System) is a catheter-based filter system that captures and removes debris dislodged during transcatheter

Date: 2023-10-19

Yoga Training and Retinal Vasculature

Status: Completed

Condition: Cognitive Change

Interventions: Participants in this group will receive high-speed yoga with cuing 3 times per week for 24 consecutive weeks for a total of 72 training sessions of 1

Date: 2023-10-19

Evaluate the Role of Soleus Muscle Exercise in Glycaemic Control in Diabetic Kidney Disease Patients

Status: NOT_YET_RECRUITING

Condition: Diabetic Kidney Disease

Interventions: Soleus muscle exercise before and after eating by half an hour

Date: 2023-10-19